摘要 |
The invention relates to a novel class of 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as a FAK and/or Pyk2 inhibitor, to a process for their preparation, and to a composition thereof, as well as to use of the compounds for the inhibiting FAK and/or Pyk2 and method for the treatment of a FAK and/or Pyk2 mediated disorder or disease. |
申请人 |
CENTAURUS BIOPHARMA CO., LTD. |
发明人 |
XIAO, DENGMING;CHENG,LIANG;LIU, XIJIE;HU, YUANDONG;XU, XINHE;LIU, ZHIHUA;ZHANG, LIPENG;WU, WEI;WANG, SHULONG;SHEN, YU;LI, GEN;WANG, YIN;ZHAO, SHENG;LI, CHONGLONG;TANG, JIA;YU, HONGHAO |